Drrx stock forecast.

The forecasts range from a low of $32.32 to a high of $38.85. ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K ... The firm increased its portfolio allocation in DRRX by 30. ...Oct 19, 2023 · The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ... Real time Durect (DRRX) stock price quote, stock graph, news & analysis.Durect Stock Chart and Share Price Forecast, Short-Term "DRRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Durect Corp (DRRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

DRRX Stock Predictions. Should I buy or sell DRRX stock? If you are thinking about buying DRRX, make sure you check out the free DRRX stock predictions report provided by MarketClub. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how DRRX will perform in the near ...

Nov 24, 2023 · DRRX Signals & Forecast. There are mixed signals in the stock today. The Durect Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. The average one-year price target for DRRX / Durect Corp is $6.885. The forecasts range from a low of $5.05 to a high of $8.925. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...

Mar-09-21 09:00AM. DURECT Corporation Announces Publication of DUR-928's Mechanism of Action. (PR Newswire) DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic …Read today's DRRX news from trusted media outlets at MarketBeat. Skip to main content. S&P 500 4,514.02. DOW 34,947.28. QQQ 386.04. S&P 500's Whirlwind: Big gains, warning whispers & tactical moves. Trading Experts Call It “The Perfect Tesla Trade” (Ad) ... Durect Shares Slide Premarket on Planned Stock Sale >DRRX marketwatch.com ...For DURECT stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average DURECT stock forecast of $0.99, a high forecast of $1.6, and a low …Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.DURECT Corporation Stock Forecast. The DURECT Corporation Stock Prediction is based on short term trend analysis and is best used for short term swing traders or day traders rather than long term investors.. Get DRRX Trend Analysis DRRX Stock Analysis. DRRX is currently in an uptrend. DRRX is up 0.00% on 11/17/23 and has gained a total …

GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.

Track Durect Corp (DRRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Get the latest TG Therapeutics Inc common stock (TGTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ...Forecst.com predicts future values using technical analysis of a large number of analytical parameters. DRRX stock returns are also predicted based on historical data. According to our research, DRRX stock is a not so good long-term investment. DRRX share price has been in a bull cycle for the past year.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.

Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ...DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average …The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...DRRX Stock Predictions. Should I buy or sell DRRX stock? If you are thinking about buying DRRX, make sure you check out the free DRRX stock predictions report provided by MarketClub. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how DRRX will perform in the near ...

May 22, 2023 · DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.

Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ...DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...DURECT Corporation stock is higher by 20.39% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives DRRX stock a score of 80 out of a possible 100.. That rank is chiefly influenced by a fundamental score of 95. In addition to the average rating …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for AYRO Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate ...View DURECT Corporation DRRX investment & stock information. Get the latest DURECT Corporation DRRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.7 Nov 2023 ... Stock DRRX logo. DRRX · DURECT Corporation Announces Topline Results ... stock at the public offering price, less underwriting discounts and ...

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.

Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median...

View more. Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Microvast Holdings Inc (MVST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Durect (NASDAQ: DRRX) is one of my favorite cheap stocks to buy right now. It’s current price looks even more tempting given the company completed a 1-to-10 stock split late last year. Durect is ...The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...DRRX Overview Stock Screener Earnings Calendar Sectors Nasdaq | DRRX U.S.: Nasdaq Durect Corp. Watch list NEW Set a price target alert Open Last Updated: Nov 24, 2023 1:00 p.m. EST Real...Durect Corp. analyst ratings, historical stock prices, earnings estimates & actuals. DRRX updated stock price target summary.Analyst Forecast. According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,883.61% from the latest price.View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.

Get the latest TG Therapeutics Inc common stock (TGTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Get the latest Galera Therapeutics Inc (GRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Price/Earnings Ratio is a widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Actual EPS (Earnings Per Share).Instagram:https://instagram. best annuities companiesesg investing companiessplg tickerbest platform to trade gold Nov 13, 2023 · Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ... buy a house with a 600 credit scoremullen automotive stocks DURECT Corporation stock is higher by 20.39% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives DRRX stock a score of 80 out of a possible 100.. That rank is chiefly influenced by a fundamental score of 95. In addition to the average rating …The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. best hedge funds in the world What is the current Price Target and Forecast for DURECT (DRRX) DURECT (DRRX) (Delayed Data from NSDQ) $0.66 USD +0.01 (1.54%) Updated Nov 24, 2023 12:59 PM …DRRX Overview Stock Screener Earnings Calendar Sectors Nasdaq | DRRX U.S.: Nasdaq Durect Corp. Watch list NEW Set a price target alert Open Last Updated: Nov 24, 2023 1:00 p.m. EST Real... (See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...